Major changes to the screening environment dictate a review of this successful program
Internationally, cervical cancer prevention programs based on cytological surveillance have been among the most successful public health achievements in modern history. Almost all developed health jurisdictions have tackled the world’s second commonest cancer among women, and implemented successful screening programs. The achievements within each country have been variable, and Australia now has the lowest mortality and second lowest incidence in the developed world1,2 (see Box).
In my capacity as member of the National Cervical Screening Program Guideline Review Committee and the CSL Limited Gardasil Advisory Board, I have received travel assistance to attend meetings.
My clinical department received research funding from Merck for participating in the initial clinical trials investigating the human papillomavirus vaccine.